Abstract
Background The first wave of the London COVID-19 epidemic peaked in April 2020. Attention initially focussed on severe presentations, intensive care capacity, and the timely supply of equipment. General practice has seen a rapid take up of technology to allow virtual consultations, enabling the management of mild and moderate community cases.
Aim To quantify the prevalence and time-course of suspected COVID-19 presenting to general practices during the London epidemic. To report disease prevalence by ethnic group, and explore how far differences by ethnicity can be explained by data in the electronic health record (EHR).
Design and Setting Cross-sectional study using anonymised data from the primary care records of 1.3 million people registered with 157 practices in four adjacent east London clinical commissioning groups (CCGs). The study area includes 48% of people from ethnic minorities and is in the top decile of social deprivation in England.
Method Suspected COVID-19 cases were identified using SNOMED codes.
Explanatory variables included age, gender, self-reported ethnicity and measures of social deprivation. Clinical factors included 16 long-term conditions, latest body mass index and smoking status.
Results There were 8,985 suspected COVID-19 cases. Ethnicity recording was 78% complete. Univariate analysis showed a two-fold increase in odds of infection for South Asian and Black adults compared to White. In a fully adjusted analysis, including clinical factors, the odds were: South Asian OR 1.93 (95% CI = 1.83 to 2.04) Black OR 1.47 (95% CI 1.38 to 1.57)
Conclusions Using data in GP records Black and south Asian ethnicity remain as predictors of community cases of COVID-19, with levels of risk similar to hospital admission cases. Further understanding of these differences requires social and occupational data.
What is known South Asian and Black ethnicity patients are at increased risk of hospital admission, intensive care admission and death from COVID-19 infection, compared with White ethnicity patients. However, little is known about the pattern of COVID-19 infection in a primary care population.
What this study adds South Asian and Black ethnicity patients are at increased risk of a suspected COVID-19 diagnosis in primary care, even after adjustment for other factors which might also be associated with increased risk.
Multimorbidity, increasing obesity and social deprivation are also strongly associated with increased risk of a suspected COVID-19 diagnosis.
Primary care recording of suspected COVID-19 diagnoses closely mirrors COVID-19 test positivity reported by the national testing scheme. Recording rates of suspected COVID-19 may provide an early warning system for any future upward trends in transmission rates.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
n/a
Funding Statement
No project specific funding was received for this research.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Information governance and ethics The clinical effectiveness group is the data processor, and the General Practices in the four CCGs are the data controllers. CEG has the written consent of all practices in the study area to use pseudonymised patient data for audit and research for patient benefit. The researchers adhere to the data protection principles of the Data Protection Act 2018, and all data was managed according to UK NHS information governance requirements. All outputs were in the form of aggregate patient data. The NHS Health Research Authority toolkit (http://www.hra-decisiontools.org.uk/ethics/) identified that Research Ethics Approval was not required for this project as all data is pseudonomised and presented in aggregate form. This was confirmed by the Chair of the North East London Strategic Information Governance Network.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data relevant to the study are included in the article
